Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Roche Innovation Center Basel, Pharmaceutical Sciences, Pharma Research and Early Development, 4070 Basel, Switzerland.
Nat Cell Biol. 2016 Jul;18(7):790-802. doi: 10.1038/ncb3371. Epub 2016 Jun 13.
Tumour-associated macrophages (TAMs) largely express an alternatively activated (or M2) phenotype, which entails immunosuppressive and tumour-promoting capabilities. Reprogramming TAMs towards a classically activated (M1) phenotype may thwart tumour-associated immunosuppression and unleash anti-tumour immunity. Here we show that conditional deletion of the microRNA (miRNA)-processing enzyme DICER in macrophages prompts M1-like TAM programming, characterized by hyperactive IFN-γ/STAT1 signalling. This rewiring abated the immunosuppressive capacity of TAMs and fostered the recruitment of activated cytotoxic T lymphocytes (CTLs) to the tumours. CTL-derived IFN-γ exacerbated M1 polarization of Dicer1-deficient TAMs and inhibited tumour growth. Remarkably, DICER deficiency in TAMs negated the anti-tumoral effects of macrophage depletion by anti-CSF1R antibodies, and enabled complete tumour eradication by PD1 checkpoint blockade or CD40 agonistic antibodies. Finally, genetic rescue of Let-7 miRNA activity in Dicer1-deficient TAMs partly restored their M2-like phenotype and decreased tumour-infiltrating CTLs. These findings suggest that DICER/Let-7 activity opposes IFN-γ-induced, immunostimulatory M1-like TAM activation, with potential therapeutic implications.
肿瘤相关巨噬细胞(TAMs)主要表达一种替代性激活(或 M2)表型,具有免疫抑制和促进肿瘤的能力。将 TAMs 重编程为经典激活(M1)表型可能会阻止肿瘤相关的免疫抑制,并释放抗肿瘤免疫。在这里,我们表明条件性敲除巨噬细胞中的 microRNA (miRNA) 加工酶 DICER 会促使 M1 样 TAM 编程,其特征是 IFN-γ/STAT1 信号过度活跃。这种重布线减弱了 TAMs 的免疫抑制能力,并促进了激活的细胞毒性 T 淋巴细胞 (CTL) 向肿瘤的募集。CTL 衍生的 IFN-γ加剧了 Dicer1 缺陷型 TAMs 的 M1 极化,并抑制了肿瘤生长。值得注意的是,TAMs 中的 DICER 缺失否定了抗 CSF1R 抗体对巨噬细胞耗竭的抗肿瘤作用,并通过 PD1 检查点阻断或 CD40 激动性抗体实现了完全的肿瘤清除。最后,Dicer1 缺陷型 TAMs 中 Let-7 miRNA 活性的基因挽救部分恢复了它们的 M2 样表型,并减少了肿瘤浸润的 CTL。这些发现表明,DICER/Let-7 活性与 IFN-γ 诱导的免疫刺激 M1 样 TAM 激活相抗衡,具有潜在的治疗意义。